Artelo Biosciences, Inc. (ARTL)

CIK 0001621221 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-03-17) · 99.1
Latest FY-2025 —
Q3-2025 —
Q2-2025 8-K (2025-07-11) · 99.1 · 99.2
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Stockholders (deficit) Equity (unaudited)
—
Consolidated Statements of Stockholders Equity
Consolidated Statements of Cash Flows
Notes
Commitments and Contengencies
—
Commitments and Contingencies
Convertible Notes
Cybersecurity Risk Management and Strategy Disclosure
—
Derivative Liabilities
—
Digital Assets
Equity
Income Taxes
—
Insider Trading Arragements
—
Insider Trading Arrangements
Intangible Asset
Lease
Organization and Description of Business
Related Party Transactions
Segment Reporting
Subsequent Events
Summary of Significant Accounting Policies